Flash FinanceUS
Market closed S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Medical Properties Trust (MPT)

Medical Properties Trust Q2 net loss narrows to $3 million; $2.4 billion debt refinancing

Positive Impact 4 of 5 financing Written later

Medical Properties Trust reported a smaller second-quarter 2026 net loss than a year earlier, with total revenues and normalized FFO both higher. The company also announced a $2.4 billion private placement and exchange of 9.25% senior secured notes due 2032, which it says is expected to close imminently and will repay 2026 notes and about half of its 2027 notes.

Key points

  • Q2 2026 net loss of $3 million ($0.01 per share), compared with a net loss of $98 million ($0.16 per share) in Q2 2025
  • Normalized FFO of $92 million ($0.15 per share), up from $81 million ($0.14 per share) a year earlier
  • Total revenues of $259.3 million for Q2 2026, compared with $240.4 million in Q2 2025
  • $2.4 billion of new 9.25% senior secured notes due 2032; proceeds to repay 2026 notes and about 50% of 2027 notes

The filing

CompanyMedical Properties Trust (MPT)
Form8-K, current report
Filed with the SECAug 10, 2026, 9:25 AM ET
Accession number0001193125-26-341434

Items reported: 2.02 Results of Operations7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 6:59 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 10, 2026.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.